Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.89)
# 818
Out of 5,182 analysts
99
Total ratings
41.24%
Success rate
13.99%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Maintains: Overweight | $22 → $40 | $29.08 | +37.55% | 1 | Apr 16, 2026 | |
| TVRD Tvardi Therapeutics | Maintains: Neutral | $4 → $3 | $3.22 | -6.83% | 2 | Apr 1, 2026 | |
| ANAB AnaptysBio | Maintains: Overweight | $67 → $95 | $50.95 | +86.46% | 2 | Mar 31, 2026 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $4 → $3 | $1.29 | +132.56% | 3 | Mar 12, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $72 → $25 | $8.90 | +180.90% | 3 | Mar 4, 2026 | |
| CLYM Climb Bio | Initiates: Overweight | $23 | $8.97 | +156.41% | 1 | Feb 13, 2026 | |
| KRRO Korro Bio | Upgrades: Overweight | $11 → $30 | $14.28 | +110.08% | 3 | Jan 29, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $450 → $1,200 | $342.57 | +250.29% | 4 | Jan 28, 2026 | |
| STTK Shattuck Labs | Initiates: Overweight | $15 | $7.88 | +90.36% | 1 | Jan 28, 2026 | |
| BIOA BioAge Labs | Initiates: Overweight | $73 | $18.80 | +288.30% | 1 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $25 | $2.50 | +900.00% | 1 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $540 → $900 | $527.11 | +70.74% | 5 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $68.87 | +8.90% | 1 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $36 | $10.79 | +233.64% | 5 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $31.67 | +146.29% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $14.10 | +41.84% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $5.59 | +365.12% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $52.67 | +175.30% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $33.97 | +50.13% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.84 | +226.09% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $14.66 | +227.42% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $90.79 | +2.43% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $9.99 | +650.75% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $100.35 | +4.63% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $33.82 | +9.40% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $5.37 | +384.17% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.96 | +2,831.94% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $40.25 | +140.99% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $28.76 | +164.26% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.56 | +602.25% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $13.99 | +114.44% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $13.16 | -8.81% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $7.43 | +1,111.31% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.42 | +3,471.43% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.61 | +185.20% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $48.22 | +92.87% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $28.53 | +99.79% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $6.44 | +940.37% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $20 | $0.85 | +2,244.12% | 5 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $105.47 | -66.82% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $13.78 | +531.35% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $6.51 | +2,588.17% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $66.14 | +8.86% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.74 | +5,295.20% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $14.62 | +2,772.78% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $95.71 | -19.55% | 1 | Jul 31, 2020 |
Roivant Sciences
Apr 16, 2026
Maintains: Overweight
Price Target: $22 → $40
Current: $29.08
Upside: +37.55%
Tvardi Therapeutics
Apr 1, 2026
Maintains: Neutral
Price Target: $4 → $3
Current: $3.22
Upside: -6.83%
AnaptysBio
Mar 31, 2026
Maintains: Overweight
Price Target: $67 → $95
Current: $50.95
Upside: +86.46%
Pliant Therapeutics
Mar 12, 2026
Maintains: Overweight
Price Target: $4 → $3
Current: $1.29
Upside: +132.56%
Arcturus Therapeutics Holdings
Mar 4, 2026
Maintains: Overweight
Price Target: $72 → $25
Current: $8.90
Upside: +180.90%
Climb Bio
Feb 13, 2026
Initiates: Overweight
Price Target: $23
Current: $8.97
Upside: +156.41%
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11 → $30
Current: $14.28
Upside: +110.08%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450 → $1,200
Current: $342.57
Upside: +250.29%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $7.88
Upside: +90.36%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $18.80
Upside: +288.30%
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $2.50
Upside: +900.00%
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $527.11
Upside: +70.74%
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $68.87
Upside: +8.90%
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $10.79
Upside: +233.64%
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $31.67
Upside: +146.29%
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $14.10
Upside: +41.84%
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $5.59
Upside: +365.12%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $52.67
Upside: +175.30%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $33.97
Upside: +50.13%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.84
Upside: +226.09%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $14.66
Upside: +227.42%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $90.79
Upside: +2.43%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $9.99
Upside: +650.75%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $100.35
Upside: +4.63%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $33.82
Upside: +9.40%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $5.37
Upside: +384.17%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.96
Upside: +2,831.94%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $40.25
Upside: +140.99%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $28.76
Upside: +164.26%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.56
Upside: +602.25%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $13.99
Upside: +114.44%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $13.16
Upside: -8.81%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $7.43
Upside: +1,111.31%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.42
Upside: +3,471.43%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.61
Upside: +185.20%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $48.22
Upside: +92.87%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $28.53
Upside: +99.79%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $6.44
Upside: +940.37%
Jul 21, 2023
Maintains: Overweight
Price Target: $13 → $20
Current: $0.85
Upside: +2,244.12%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $105.47
Upside: -66.82%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $13.78
Upside: +531.35%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $6.51
Upside: +2,588.17%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $66.14
Upside: +8.86%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.74
Upside: +5,295.20%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $14.62
Upside: +2,772.78%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $95.71
Upside: -19.55%